181 related articles for article (PubMed ID: 32763976)
1. Alternative splicing reverses the cell-intrinsic and cell-extrinsic pro-oncogenic potentials of YAP1.
Ben C; Wu X; Takahashi-Kanemitsu A; Knight CT; Hayashi T; Hatakeyama M
J Biol Chem; 2020 Oct; 295(41):13965-13980. PubMed ID: 32763976
[TBL] [Abstract][Full Text] [Related]
2. Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancer.
Chen MJ; Wang YC; Wu DW; Chen CY; Lee H
Pathol Res Pract; 2019 Apr; 215(4):801-806. PubMed ID: 30685130
[TBL] [Abstract][Full Text] [Related]
3. YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function.
Tsutsumi R; Masoudi M; Takahashi A; Fujii Y; Hayashi T; Kikuchi I; Satou Y; Taira M; Hatakeyama M
Dev Cell; 2013 Sep; 26(6):658-65. PubMed ID: 24035415
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor 2α (HIF-2α) promotes colon cancer growth by potentiating Yes-associated protein 1 (YAP1) activity.
Ma X; Zhang H; Xue X; Shah YM
J Biol Chem; 2017 Oct; 292(41):17046-17056. PubMed ID: 28848049
[TBL] [Abstract][Full Text] [Related]
5. Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis.
Subramaniam D; Ponnurangam S; Ramalingam S; Kwatra D; Dandawate P; Weir SJ; Umar S; Jensen RA; Anant S
Cells; 2021 Jun; 10(7):. PubMed ID: 34206989
[TBL] [Abstract][Full Text] [Related]
6. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.
Ota M; Sasaki H
Development; 2008 Dec; 135(24):4059-69. PubMed ID: 19004856
[TBL] [Abstract][Full Text] [Related]
7. The WW domains dictate isoform-specific regulation of YAP1 stability and pancreatic cancer cell malignancy.
Guo Q; Quan M; Dong J; Bai J; Wang J; Han R; Wang W; Cai Y; Lv YQ; Chen Q; Xu H; Lyu HD; Deng L; Zhou D; Xiao X; De Langhe S; Billadeau DD; Lou Z; Zhang JS
Theranostics; 2020; 10(10):4422-4436. PubMed ID: 32292505
[TBL] [Abstract][Full Text] [Related]
8. PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis.
Wang Y; Justilien V; Brennan KI; Jamieson L; Murray NR; Fields AP
Oncogene; 2017 Jan; 36(4):534-545. PubMed ID: 27321186
[TBL] [Abstract][Full Text] [Related]
9. Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic β-Catenin, PIK3CA and MET.
Liu JJ; Li Y; Chen WS; Liang Y; Wang G; Zong M; Kaneko K; Xu R; Karin M; Feng GS
J Hepatol; 2018 Jul; 69(1):79-88. PubMed ID: 29505847
[TBL] [Abstract][Full Text] [Related]
10. ERG Activates the YAP1 Transcriptional Program and Induces the Development of Age-Related Prostate Tumors.
Nguyen LT; Tretiakova MS; Silvis MR; Lucas J; Klezovitch O; Coleman I; Bolouri H; Kutyavin VI; Morrissey C; True LD; Nelson PS; Vasioukhin V
Cancer Cell; 2015 Jun; 27(6):797-808. PubMed ID: 26058078
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic KRAS signaling and YAP1/β-catenin: Similar cell cycle control in tumor initiation.
Nussinov R; Tsai CJ; Jang H; Korcsmáros T; Csermely P
Semin Cell Dev Biol; 2016 Oct; 58():79-85. PubMed ID: 27058752
[TBL] [Abstract][Full Text] [Related]
12. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.
Wu Y; Zheng Q; Li Y; Wang G; Gao S; Zhang X; Yan X; Zhang X; Xie J; Wang Y; Sun X; Meng X; Yin B; Wang B
J Exp Clin Cancer Res; 2019 Aug; 38(1):376. PubMed ID: 31455378
[TBL] [Abstract][Full Text] [Related]
13. YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis.
Pajtler KW; Wei Y; Okonechnikov K; Silva PBG; Vouri M; Zhang L; Brabetz S; Sieber L; Gulley M; Mauermann M; Wedig T; Mack N; Imamura Kawasawa Y; Sharma T; Zuckermann M; Andreiuolo F; Holland E; Maass K; Körkel-Qu H; Liu HK; Sahm F; Capper D; Bunt J; Richards LJ; Jones DTW; Korshunov A; Chavez L; Lichter P; Hoshino M; Pfister SM; Kool M; Li W; Kawauchi D
Nat Commun; 2019 Sep; 10(1):3914. PubMed ID: 31477715
[TBL] [Abstract][Full Text] [Related]
14. TEAD4 promotes colorectal tumorigenesis via transcriptionally targeting YAP1.
Tang JY; Yu CY; Bao YJ; Chen L; Chen J; Yang SL; Chen HY; Hong J; Fang JY
Cell Cycle; 2018; 17(1):102-109. PubMed ID: 29157094
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E
Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ
Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128
[TBL] [Abstract][Full Text] [Related]
16. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
[TBL] [Abstract][Full Text] [Related]
17. YAP1 and PRDM14 converge to promote cell survival and tumorigenesis.
Kim M; Ly SH; Xie Y; Duronio GN; Ford-Roshon D; Hwang JH; Sulahian R; Rennhack JP; So J; Gjoerup O; Talamas JA; Grandclaudon M; Long HW; Doench JG; Sethi NS; Giannakis M; Hahn WC
Dev Cell; 2022 Jan; 57(2):212-227.e8. PubMed ID: 34990589
[TBL] [Abstract][Full Text] [Related]
18. The YAP-Interacting Phosphatase SHP2 Can Regulate Transcriptional Coactivity and Modulate Sensitivity to Chemotherapy in Cholangiocarcinoma.
Buckarma EH; Werneburg NW; Conboy CB; Kabashima A; O'Brien DR; Wang C; Ilyas SI; Smoot RL
Mol Cancer Res; 2020 Oct; 18(10):1574-1588. PubMed ID: 32646966
[TBL] [Abstract][Full Text] [Related]
19. Tumorigenic role of YAP in hepatocellular carcinogenesis is involved in SHP2 whose function is different in vitro and in vivo.
Kim MK; Park JY; Kang YN
Pathol Res Pract; 2018 Jul; 214(7):1031-1039. PubMed ID: 29699904
[TBL] [Abstract][Full Text] [Related]
20. Sprouty2-modulated Kras signaling rescues Shp2 deficiency during lens and lacrimal gland development.
Pan Y; Carbe C; Powers A; Feng GS; Zhang X
Development; 2010 Apr; 137(7):1085-93. PubMed ID: 20215346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]